FII Holdings

AAREY DRUGS & PHARMACEUTICALS LTD.

NSE : AAREYDRUGSBSE : 524412ISIN CODE : INE198H01019Industry : Pharmaceuticals & DrugsHouse : Aarey
BSE50.502.01 (+4.15 %)
PREV CLOSE ( ) 48.49
OPEN PRICE ( ) 49.10
BID PRICE (QTY) 50.91 (211)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 33839
TODAY'S LOW / HIGH ( )48.75 50.91
52 WK LOW / HIGH ( )26.82 68
NSE50.752.4 (+4.96 %)
PREV CLOSE( ) 48.35
OPEN PRICE ( ) 49.00
BID PRICE (QTY) 50.75 (23435)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 99908
TODAY'S LOW / HIGH( ) 48.70 50.75
52 WK LOW / HIGH ( )27 68
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202403 % of Share Quarter Ended 202312 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.